DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Lefebvre P, Coleman CI, Bookhart BK. , et al.
Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism.
J Med Econ 2014;
17 (01) 52-64
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.